Personalised cancer vaccine with immunotherapy reduces melanoma recurrence after surgery
AI drug choices may cost millions
Researchers reprogramme pancreatic cancer tumour microenvironment
Base to Base biotech podcast 81: Breakthrough in shrinking tumours and restoring mitochondrial metabolism to address obesity
Insilico Medicine announces $888m collaboration with Servier
Base to Base biotech podcast 39: Gene therapy for eye problems, GAIA, and separation science
ChemLex raises $45m and launches lab for drug discovery in Singapore
Base to Base biotech podcast 37: Life Sciences in Flanders, AI and drug discovery, and healthcare investment
Faster and more reliable dementia diagnosis
Base to Base biotech podcast 36: Gothenburg, Charcot-Marie-Tooth disease and Ultrasound AI
SAS Clinical Acceleration debuts to modernise clinical trials and accelerate time to market
China’s first AI drug completes phase III trial